Research was undertaken between January and November 2020, to determine approaches and challenges to spread and adoption across the AHSN Network – focusing on the period January 2018 to January 2020.

The study sought to:

  • Generate a before unknown aggregated view of approaches and challenges
  • Understand the range and type of approaches in use
  • Explore one AHSN national programme (TCAM) in depth
  • Share learning back to AHSNs and beyond
  • Further increase the 15 AHSNs’ capability to spread innovation.

Read the full document

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]

  • Prevention may be the cure, but innovation the best course of treatment

    Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer.  The new Government has rightly declared its focus on moving the [...]